Vita Life Sciences Limited (ASX: VLS)
Health Care · Pharmaceuticals · AU
AU$2.78
-0.71% today · +14.9% 1Y
Vita Life Sciences Limited (ASX: VLS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $104.53M and employs 400 people.
Over the last twelve months the share price has gained 14.9%, trading between 2.27 and 2.84.
Tweenvest scores Vita Life Sciences Limited across four factors: quality 87/100, value 56/100, growth 67/100, dividend 99/100. Its strongest factor is dividend.
VLS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $104.53M
- Revenue (TTM)
- $66.43M
- P/E
- 14.07
- EPS
- 0.20
- Dividend yield
- 5.04%
- Beta (5Y)
- 0.53
- 52-week high
- AU$2.84
- 52-week low
- AU$2.27
- Avg volume (3M)
- —
- Shares outstanding
- 54.07M
- Employees
- 400
- Next earnings
- —
About Vita Life Sciences Limited
Vita Life Sciences Limited is an Australian healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and nutritional supplements. The company's reach spans Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. In addition to core supplements, their product range encompasses minerals, various herbs, and superfoods. They offer solutions targeting a broad spectrum of therapeutic areas, including nervous system support, general nutrition, immunity, hair, skin, and nails, liver and digestion, weight management, cardiovascular health, pain and inflammation, pregnancy and breastfeeding, and health specifically for men, women, and children. Products also provide antioxidant benefits and support for bones and joints. Marketed under their prominent brands—Herbs of Gold, VitaHealth, and VitaScience—these offerings are sold through pharmacies and health food channels. Established in 1947, Vita Life Sciences Limited is headquartered in Kirrawee, Australia.
- ISIN
- AU000000VLS8
- Founded
- 1947
- Listed since
- Jul 9, 2007
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd.TPEX: 1777 | $105.57M | NT$75.70 | +1.75% |
| Jushi Holdings Inc.OTCPK: JUSH | $105.41M | $0.53 | -7.39% |
| Cumberland Pharmaceuticals Inc.NasdaqGS: CPIX | $105.33M | $7.14 | +1.56% |
| Nang Kuang Pharmaceutical Co., Ltd.TWSE: 1752 | $105.02M | NT$33.25 | +5.72% |
| Aardvark Therapeutics, Inc.NasdaqGS: AARD | $104.17M | $4.45 | -6.51% |
| Themis Medicare LimitedBSE: 530199 | $103.78M | Rs109.05 | -4.43% |
| PolyPid Ltd.NasdaqCM: PYPD | $102.98M | $5.08 | +0.20% |
| Bafna Pharmaceuticals LimitedNSEI: BAFNAPH | $102.17M | Rs418.00 | +10.36% |
Figures last refreshed Oct 11, 2026.